TIF continues the efforts to address the questions and concerns of its global patients’ and healthcare professionals’ community about the COVID-19 Pandemic and, in doing so, it has issued 2 brand new informational documents. The TIF-proposed Haemoglobinopathy Patient Pathway for Day Care Centres, Units and Clinics treating patients with thalassaemia ...
Read More »
Therapeutic advances in β-thalassaemia have gradually led to a significant improvement in prognosis over the past few decades. As a result, patients living in areas where disease specific programmes offer access to modern therapies, experience a new era of prolonged survival that tends to reach that of the normal population. ...
Read More »
On Friday, 20 March, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response. Hydroxychloroquine and a related drug, chloroquine, are currently under evaluation in clinical trials for the treatment of COVID-19. When supported for use in COVID-19 ...
Read More »
The application period for the ‘Panos Englezos Prize 2020‘ is now open
Read More »
OUR SPECIALIST TEAM: Prof John Porter, Supervisor Dr Perla Eleftheriou, Coordinator and many other valuable colleagues. FUNDING: A stipend of $2000 USD/month for each successful candidate, which intends to cover the successful candidate’s accommodation, daily transportation and basic living expenses. Any expenses above this amount will be the responsibility of the ...
Read More »
TIF
